Sirtris Pharmaceuticals
Sirtris Pharmaceuticals develops small molecule drugs for the treatment of aging and metabolic diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD982m (Public information from Apr 2008)
Cambridge Massachusetts (HQ)
Authorizing premium user...